Volume 6 Issue 8, Aug 2021

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 6 Issue 8, Aug 2021:
Research Highlight
A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus
Junzhi Wang